Top Health Tech Companies in Minneapolis, MN (112)

Profitability: Margins and earnings are expanding, with Q1 FY2026 adjusted EBITDA up, gross margin at 30.1%, and positive net income. FY2025 also delivered record free cash flow alongside margin expansion.

Customer Loyalty & Retention: Autoship represents a large, recurring base at 84.4% of Q1 FY2026 net sales, growing at a double‑digit pace. Rising net sales per active customer and cross‑category engagement point to stickier spend and retention.

Diversified Revenue Streams: Pet health services are scaling through SmartPak and the Modern Animal acquisition, complementing core e‑commerce with clinics and pharmacy. The Modern Animal deal is expected to add over $125M in annualized run‑rate revenue and expand clinics from 18 to 47, with additional openings planned in FY2026.

Strong Revenue Growth: Consolidated revenues increased from $253 billion in 2024 to $270.6 billion in 2025, with quarterly gains such as Q4 2025 up 8% year over year. Growth was led primarily by Optum Rx and supported by steady contributions from Optum Insight.

Market Expansion: Expansion through acquisitions such as Holston Medical Group (August 2025) and Alegeus (July 2026), alongside earlier combinations like Change Healthcare and Atrius Health, broadened capabilities across care, pharmacy, and payments. These moves extend Optum’s platform into adjacent services and operating domains.

Diversified Revenue Streams: A multi-segment model—Rx, Insight, and Health—helps sustain aggregate growth even as individual lines vary, with pharmacy and technology businesses offsetting care-delivery softness. Parent-company commentary continuing to frame Optum as a growth engine and raising 2026 guidance underscores the benefit of this portfolio effect.

Strong Market Position & Advantage: The company is described as a top‑tier distributor in North American dental and a leading player in animal health, supported by long operating history and logistical moats. Its role alongside Henry Schein in an oligopolistic dental channel, and leadership in the U.K. via NVS, indicate durable competitive positioning.

Diversified Revenue Streams: Operations span two large divisions—Dental and Animal Health—complemented by value‑added services and software. This mix has provided some balance, with steadier Animal Health trends partially offsetting softer Dental performance.

Investor Backing & Capital Strength: The acquisition by Patient Square Capital supplies committed sponsorship and resources for the next phase under private ownership. Leadership changes and continued bolt‑on deals signal a capital‑supported agenda for operational improvements and selective expansion.

Strong Market Position & Advantage: The company is repeatedly characterized as the nation’s leading or premier platform for integrating health and social care, powering the largest outcomes-driven network with broad statewide programs and measurable impact. Recognition such as inclusion on TIME’s 2025 World’s Top HealthTech Companies and large-scale deployments reinforce a durable competitive position.

Strategic Partnerships: Relationships span major health systems and insurers and statewide government initiatives, alongside backing from prominent investors. State Medicaid initiatives and Social Care Networks selecting the platform indicate embedded ties across payers, providers, and community organizations.

Innovation-Driven Growth: Acquisitions like Carrot Health and NowPow expanded analytics and referral capabilities, while product enhancements added predictive analytics, closed-loop referrals, and integrated eligibility and payments. Ongoing platform updates and AI-driven features are intended to improve ROI and accelerate adoption.

Cost & Operational Efficiency: Restructuring actions and a deliberate shift toward higher‑margin technology and applications are improving adjusted profitability and targeting stronger operating leverage. Management cites material annualized savings and contract changes designed to sustain margin gains.

Innovation-Driven Growth: The Ignite platform and AI initiatives (including Ignite Intelligence and Ignite Spark) are characterized as modular, flexible upgrades that shorten sales cycles and expand accessibility. Cloud- and data‑platform partnerships reinforce a modern architecture supporting product momentum.

Strong Brand Reputation: Recognition by respected industry and media organizations (e.g., Newsweek, TIME, Frost & Sullivan) underscores standing as a leading healthcare analytics provider. Workplace accolades and a broad installed base further reinforce credibility and trust.

Strong Market Position & Advantage: Industry recognition in payer quality measurement/reporting and payer‑focused data platforms is consistently cited, supported by long‑running certifications and broad health‑plan adoption. Third‑party benchmarks and awards reinforce a leadership foothold in these core categories.

Strong Revenue Growth: Company communications describe multi‑year double‑digit growth since privatization, alongside statements of expanding customer counts and dataset scale. These signals are presented as outcomes of a shift to a pure‑play cloud platform and continued commercial traction.

Innovation-Driven Growth: The shift to a cloud SaaS/Data platform, addition of AI‑enabled features, and a consolidated application portal indicate an emphasis on product velocity. New solution launches and ongoing enhancements are showcased alongside recognitions tied to specific offerings.

Strong Revenue Growth: Reported results show revenue and operating income increased year over year alongside higher outpatient visits, admissions, and procedures. This trajectory indicates growing demand supporting continued scaling across sites.

Innovation-Driven Growth: Investments in AI, robotics, automation, and the Mayo Clinic Platform are being integrated with patient-centered care and have earned recognition for digital excellence. These innovation programs are expanding clinical capabilities and platform reach beyond bricks-and-mortar.

Future-Ready Strategy: Bold. Forward. Unbound. outlines multi-year, systemwide expansions in Minnesota, Arizona, and Florida that blend inpatient and outpatient models with digitally enabled care. Leadership characterizes these builds as major building blocks for transformation to meet rising complex-care demand.

Strong Revenue Growth: Revenue from continuing operations grew 9% in FY2026 with 7% constant-currency organic growth, extending momentum from FY2025. Guidance for FY2027 calls for 7–8% reported revenue growth and 9–11% adjusted EPS growth.

Healthy Cash Flow: Operating cash flow reached about $1.34B and free cash flow was $983M in FY2026, both above the prior year. A new $1B share repurchase authorization underscores capacity to return capital.

Strong Market Position & Advantage: STERIS is widely viewed as a leader across infection prevention and sterilization, often top‑two with Getinge in equipment and co‑leading outsourced sterilization with Sotera. Competitor filings explicitly naming STERIS AST as a primary rival validate its top‑tier standing.

Strong Market Position & Advantage: Available information indicates Healthline Media is consistently among the most-visited health information sites and that RVO’s combined portfolio places it among top U.S. consumer digital health platforms. Leadership varies by sub-vertical, but overall audience scale and breadth are sustained at a top-tier level.

Product Line Growth: New offerings such as Optum Perks telehealth, the Fullspan Health platform for life sciences, and the integration of AI-driven guidance expand capabilities from information into care access and patient services. The acquisition of Vincere Health further adds behavior-change and engagement features to core programs.

Strategic Partnerships: Tie-ups with Ada Health and Zocdoc extend technology, booking, and engagement pathways across the patient journey. These relationships strengthen the ability to move users from content to transactions and care.